These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18423739)

  • 1. Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles.
    Helfand BT; Loeb S; Cashy J; Meeks JJ; Thaxton CS; Han M; Catalona WJ
    J Urol; 2008 Jun; 179(6):2197-201; discussion 2202. PubMed ID: 18423739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease.
    Hamano T; Matsui H; Sekine Y; Ohtake N; Nakata S; Suzuki K
    J Urol; 2010 Aug; 184(2):738-42. PubMed ID: 20639049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population.
    Wokołorczyk D; Gliniewicz B; Stojewski M; Sikorski A; Złowocka E; Debniak T; Jakubowska A; Górski B; van de Wetering T; Narod SA; Lubiński J; Cybulski C
    Eur J Cancer Prev; 2010 Mar; 19(2):167-71. PubMed ID: 19952762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study.
    Severi G; Hayes VM; Padilla EJ; English DR; Southey MC; Sutherland RL; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):610-2. PubMed ID: 17372260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.
    Wang L; McDonnell SK; Slusser JP; Hebbring SJ; Cunningham JM; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Cancer Res; 2007 Apr; 67(7):2944-50. PubMed ID: 17409399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
    Meyer A; Schürmann P; Ghahremani M; Kocak E; Brinkhaus MJ; Bremer M; Karstens JH; Hagemann J; Machtens S; Dörk T
    Urol Oncol; 2009; 27(4):373-6. PubMed ID: 18625567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
    Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
    Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease.
    Bao BY; Pao JB; Lin VC; Huang CN; Chang TY; Lan YH; Lu TL; Lee HZ; Chen LM; Ting WC; Hsieh CJ; Huang SP
    Clin Chim Acta; 2010 Sep; 411(17-18):1232-7. PubMed ID: 20450899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.
    Cussenot O; Azzouzi AR; Bantsimba-Malanda G; Gaffory C; Mangin P; Cormier L; Fournier G; Valeri A; Jouffe L; Roupret M; Fromont G; Sibony M; Comperat E; Cancel-Tassin G
    Clin Cancer Res; 2008 Sep; 14(17):5635-9. PubMed ID: 18765558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rs1447295 at 8q24 is a risk variant for prostate cancer in Taiwanese men.
    Chen M; Huang YC; Ko IL; Yang S; Chang YH; Huang WJ; Chen YM
    Urology; 2009 Sep; 74(3):698-701. PubMed ID: 19428064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MTHFR 677C --> T polymorphism and risk of prostate cancer: results from the CAPS study.
    Johansson M; Van Guelpen B; Hultdin J; Wiklund F; Adami HO; Bälter K; Grönberg H; Stattin P
    Cancer Causes Control; 2007 Dec; 18(10):1169-74. PubMed ID: 17846906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of family history on outcomes in patients treated with definitive brachytherapy for clinically localized prostate cancer.
    Peters CA; Stock RG; Blacksburg SR; Stone NN
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):24-9. PubMed ID: 18692325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of the CYP11A1 (TTTTA)6 allele increases the risk of biochemical relapse in organ confined and low-grade prostate cancer.
    Celhar T; Gersak K; Ovcak Z; Sedmak B; Mlinaric-Rascan I
    Cancer Genet Cytogenet; 2008 Nov; 187(1):28-33. PubMed ID: 18992638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
    Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A replication study examining association of rs6983267, rs10090154, and rs1447295 common single nucleotide polymorphisms in 8q24 region with prostate cancer in Siberians.
    Oskina NA; Boyarskikh UA; Lazarev AF; Petrova VD; Ganov DI; Tonacheva OG; Lifshits GI; Filipenko ML
    Urol Oncol; 2014 Jan; 32(1):37.e7-12. PubMed ID: 23628314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy--can we predict adverse pathological outcomes?
    Thong AE; Shikanov S; Katz MH; Gofrit ON; Eggener S; Zagaja GP; Shalhav AL; Zorn KC
    J Urol; 2008 Dec; 180(6):2436-40. PubMed ID: 18930486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
    Paz-y-Miño C; Witte T; Robles P; Llumipanta W; Díaz M; Arévalo M
    Cancer Genet Cytogenet; 2009 Mar; 189(2):71-6. PubMed ID: 19215786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of chromosome 8q24 variants with prostate cancer risk in the Siberian region of Russia and meta-analysis].
    Os'kina NA; Boiarskikh UA; Lazarev AF; Petrova VD; Ganov DI; Tonacheva OG; Lifshits GI; Filipenko ML
    Mol Biol (Mosk); 2012; 46(2):234-41. PubMed ID: 22670519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.
    Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V
    Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.